0001209191-20-008870.txt : 20200212
0001209191-20-008870.hdr.sgml : 20200212
20200212171455
ACCESSION NUMBER: 0001209191-20-008870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yuchun
CENTRAL INDEX KEY: 0001334365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20605398
MAIL ADDRESS:
STREET 1: 170 TRACER LA.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001334365
Lee Yuchun
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2020-02-10
4
M
0
1181
57.27
A
3056
D
Common Stock
2020-02-10
4
S
0
120
240.04
D
2936
D
Common Stock
2020-02-10
4
S
0
360
241.61
D
2576
D
Common Stock
2020-02-10
4
S
0
360
242.86
D
2216
D
Common Stock
2020-02-10
4
S
0
229
243.55
D
1987
D
Common Stock
2020-02-10
4
S
0
112
244.79
D
1875
D
Stock Options (Right to Buy)
57.27
2020-02-10
4
M
0
1181
0.00
D
2022-09-13
Common Stock
1181
13125
D
Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $240.04 (range $239.59 to $240.49).
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $241.61 (range $241.26 to $241.87).
Open market sales reported on this line occurred at a weighted average price of $242.86 (range $242.37 to $243.36).
Open market sales reported on this line occurred at a weighted average price of $243.55 (range $243.46 to $243.72).
Open market sales reported on this line occurred at a weighted average price of $244.79 (range $244.78 to $244.84).
Fully vested.
/s/ Omar White, Attorney-in-Fact
2020-02-12